SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL

Irene Chivato Martín-Falquina  1     Blanca Vicente González  2     Lara Arias-García  2     Natalia Revilla Cuesta  2     ROSA MARIA SAIZ CHUMILLAS  2     Beatriz Sicilia Aladrén  3    
1 Hospital Universitario Burgos, Burgos, Spain
2 Hospital Universitario de Burgos, Burgos, Spain
3 H Universitario de Burgos, Burgos, Spain

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing